Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

Not my math Xena. It does have SOME merit in its methodology
of timing and cash to balance sheet.

Certainly enough money at present to pay salaries and incidental
expenses since many think the burn rate for ongoing "research"
is negligible. I, however, happen to disagree. I expect some
financial mechanism going forward BEFORE ANY future trial
enlists even one patient through a CRO.

Contrarian Opinion? I think it is actually more widely held than admitted.
As much as I often enjoy Jimmy's musings, one year later than cite
rings hollow for any intervening reality.